Cargando…

An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis

Introduction: With the increasing use of immune checkpoint inhibitors (ICI) for cancer, there is a growing burden on the healthcare system to provide care for the toxicities associated with these agents. Herein, we aim to identify and describe the distribution of encounters seen in an urgent care se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Kai-li, Tackett, Sean, Myers, Samantha, Brahmer, Julie R., Browner, Ilene S., Ettinger, David S., Forde, Patrick M., Hales, Russell K., Hann, Christine L., Lam, Vincent K., Marrone, Kristen A., Patel, Tricia, Peterson, Valerie, Sagorsky, Sarah, Turner, Michelle, Voong, Khinh R., Naidoo, Jarushka, Feliciano, Josephine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221771/ https://www.ncbi.nlm.nih.gov/pubmed/35735456 http://dx.doi.org/10.3390/curroncol29060347

Ejemplares similares

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
por: Hsu, Melinda L, et al.
Publicado: (2022)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes
por: Balaji, Aanika, et al.
Publicado: (2021)

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer
por: Voong, Khinh Ranh, et al.
Publicado: (2020)

Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
por: Scott, Susan C., et al.
Publicado: (2022)

Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study
por: Voong, Khinh Ranh, et al.
Publicado: (2023)

CLRM-11 ALK TYROSINE KINASE INHIBITOR THERAPY AND BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER: IMPACT ON TUMOR SIZE AND DISTRIBUTION
por: Kamson, David Olayinka, et al.
Publicado: (2023)

Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
por: Ghanem, Paola, et al.
Publicado: (2023)

Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact
por: Hazell, Sarah Z., et al.
Publicado: (2020)

Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer
por: Wills, Beatriz, et al.
Publicado: (2018)

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
por: Marrone, Kristen A., et al.
Publicado: (2018)

Radiologic response of chemotherapy alone versus radiation and chemotherapy in the treatment of locally‐advanced or advanced thymic epithelial tumors
por: Chu, Robert F., et al.
Publicado: (2020)

Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis
por: Sloan, Lindsey, et al.
Publicado: (2022)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
por: Naidoo, Jarushka, et al.
Publicado: (2017)

Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
por: Naidoo, Jarushka, et al.
Publicado: (2020)

DAART: a deep learning platform for deeply accelerated adaptive radiation therapy for lung cancer
por: Hooshangnejad, Hamed, et al.
Publicado: (2023)

Glioblastoma in older adults
por: Holdhoff, Matthias, et al.
Publicado: (2018)

Persistent mutation burden drives sustained anti-tumor immune responses
por: Niknafs, Noushin, et al.
Publicado: (2023)

A Multidisciplinary Approach for Patients with Preexisting Lung Diseases and Immune Checkpoint Inhibitor Toxicities
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
por: Bredin, Philip, et al.
Publicado: (2022)

Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity
por: Cluxton, Christopher, et al.
Publicado: (2023)

Evaluating Proton Dose and Associated Range Uncertainty Using Daily Cone-Beam CT
por: Li, Heng, et al.
Publicado: (2022)

Immune-Related Adverse Events: A Case-Based Approach
por: Connolly, Caoilfhionn, et al.
Publicado: (2019)

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs
por: Balaji, Aanika, et al.
Publicado: (2020)

The 2014 San Antonio Breast Cancer Symposium: A successful lift-off for breast immunotherapy?
por: Page, David B, et al.
Publicado: (2015)

Truly Urgent “Urgent-Start” Peritoneal Dialysis
por: Chiu, Michael, et al.
Publicado: (2020)

An urgent call to raise the bar in oncology
por: Schnog, John-John B., et al.
Publicado: (2021)

Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival
por: Yarchoan, Mark, et al.
Publicado: (2015)

Successful Treatment of Scar Pain with Scrambler Therapy
por: Yarchoan, Mark, et al.
Publicado: (2019)

From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Post-operative ctDNA monitoring in stage I colon cancer: A case report
por: Alden, Stephanie L., et al.
Publicado: (2022)

Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
por: Paller, Channing J., et al.
Publicado: (2023)

Is it possible to adopt the same oncological approach in urgent surgery for colon cancer?
por: Yoshida, Bruno Yuki, et al.
Publicado: (2022)

Advanced Practice Provider Model for Urgent Oncology Care
por: Iannelli, Marie, et al.
Publicado: (2023)

Ecopharmacovigilance: An issue urgently to be addressed
por: Medhi, Bikash, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gsepuahvi5pbcqv9ib5ocvsht3